Invention Grant
- Patent Title: Cell-free combination, hydrogel-like material or hydrogel and use of same
-
Application No.: US16609041Application Date: 2018-04-24
-
Publication No.: US11324855B2Publication Date: 2022-05-10
- Inventor: Christoph Gaissmaier , Nils Clausen , Karin Benz
- Applicant: TETEC TISSUE ENGINEERING TECHNOLOGIES AG
- Applicant Address: DE Reutlingen
- Assignee: TETEC TISSUE ENGINEERING TECHNOLOGIES AG
- Current Assignee: TETEC TISSUE ENGINEERING TECHNOLOGIES AG
- Current Assignee Address: DE Reutlingen
- Agency: Lewis Kohn & Walker LLP
- Agent David M. Kohn
- Priority: DE102017207049.8 20170426
- International Application: PCT/EP2018/060486 WO 20180424
- International Announcement: WO2018/197500 WO 20181101
- Main IPC: A61L27/34
- IPC: A61L27/34 ; A61L27/22 ; A61L27/52 ; A61L27/54 ; A61K9/00

Abstract:
A cell-free combination for use in the controlled, especially decelerated or retarded, release of active ingredient and/or in the production of a formulation in hydrogel form, especially depot formulation in hydrogel form, and/or as a formulation in hydrogel form, especially depot formulation in hydrogel form, and/or for the coating of a medical product, especially implant, preferably with a formulation in hydrogel form, especially depot formulation in hydrogel form, wherein the cell-free combination comprises a first component and a second component, the first component comprising crosslinkable albumin and the second component comprising a crosslinking agent for the albumin. Additionally, a hydrogel-forming material or hydrogel, to a kit or multicomponent system, to a medical product or a pharmaceutical formulation, to a discharge device, and to uses of the cell-free combination and of the hydrogel-forming material or hydrogel.
Public/Granted literature
- US20200147263A1 Cell-free Combination, Hydrogel-like Material or Hydrogel and Use of Same Public/Granted day:2020-05-14
Information query